Concepedia

Xiaodong Luo

XL

Statistics

Publications

31

Citations

1K

H-Index

17

Active since

1997

Affiliations

Sanofi (United States)(Current)

Chinese Academy of Sciences

Janssen (United States)

Pfizer (United States)

Second Affiliated Hospital of Chongqing Medical University

Xiaodong Luo is an author at Sanofi (United States) specializing in medicine, statistics, and biostatistics.

ORCID

Top concepts

Publications per year

1997–2024

31

Publications

31

Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial

Klaus F. Rabe, Bartolomé R. Celli, Michael E. Wechsler et al. · The Lancet Respiratory Medicine · 2021 · 188 citations

, , +5

An Alternative Approach to Confidence Interval Estimation for the Win Ratio Statistic

Xiaodong Luo, Hong Tian, Surya Mohanty et al. · Biometrics · 2014 · 83 citations · Full text

Inhibition of enterovirus 71 replication by chrysosplenetin and penduletin

Qinchang Zhu, Yi Wang, Yaping Liu et al. · European Journal of Pharmaceutical Sciences · 2011 · 69 citations

, , +3

A proportional likelihood ratio model

Xiaodong Luo, Wei‐Yann Tsai · Biometrika · 2011 · 49 citations

Nonparametric estimation for right-censored length-biased data: a pseudo-partial likelihood approach

Xiaodong Luo, Wei‐Yann Tsai · Biometrika · 2009 · 47 citations

1–5 of 31